Company intelligence / Profile preview

AcuShot

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

AcuShot develops hi-tech solutions aimed at protecting livestock—specifically cattle and pigs—from infectious diseases. The company appears to focus on innovative device-based approaches rather than pharmaceuticals or biologics. No clinical trial data is referenced, as this is likely a veterinary device/platform.

Therapeutic areas: Infectious Diseases
Modalities: DeviceNon-pharmacological therapy
Industry: Veterinary

Beyond the preview

Go deeper on AcuShot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AcuShot.

Explore the full profile